• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Oxford BioDynamics signs deal to develop ASD biomarkers pharmatimes
    November 14, 2018
    Oxford BioDynamics (OBDs) has signed a collaboration agreement with Italian research and biomedical institute Casa Sollievo della Sofferenza to develop a diagnostic biomarker assay for Autism Spectrum Disorder (ASD).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service